- cafead   Jan 03, 2024 at 09:52: AM
via The antibody-drug conjugate market is picking up right where it left off in 2023 as Roche has made a potential $1 billion deal with China-based MediLink Therapeutics to develop a next-generation ADC in oncology, the Chinese biotech announced on Tuesday.
article source
article source